Trials / Unknown
UnknownNCT01000129
Adaptive Planning in Bladder Cancer
Adaptive - Predictive Planning for Hypofractionated Bladder Radiotherapy
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate that radiotherapy treatments for bladder cancer can be delivered with greater accuracy using a new planning method and that this method can be used simply and effectively by those delivering treatment.
Detailed description
This study integrates a novel adaptive planning methodology, Adaptive-Planning Organ LOcalisation (A-POLO), with optimised margins and cone beam CT technology for improving the accuracy of radiotherapy treatment delivery. The previous study (CCR2873, REC 07/Q0801/13) evaluated the use of cone beam CT in radiotherapy for bladder cancer. A larger than expected number of bladder radiotherapy treatments were seen to have been delivered with some element of geographic miss. Using the novel adaptive planning method these fractions of radiotherapy could have been correctly treated. The feasibility of this method has been proven in the previous study, particularly it has been shown that this method is appropriate and provides a simple solution to the problem. It can be carried out by the radiographers at the treatment unit without adding extra time to the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Adaptive-Planning Organ Localisation (A-POLO) (Planning CT scan) | Planning CT scan performed by qualified planning radiographers |
| OTHER | Cone beam CT acquisition | Cone beam CT acquisition performed by therapy radiographers who have training and experience of using cone beam CT. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2009-10-22
- Last updated
- 2009-10-22
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01000129. Inclusion in this directory is not an endorsement.